PPARα and PPARγ activation is associated with pleural mesothelioma invasion but therapeutic inhibition is ineffective.
Saved in:
| Title: | PPARα and PPARγ activation is associated with pleural mesothelioma invasion but therapeutic inhibition is ineffective. |
|---|---|
| Authors: | Orozco Morales ML; School of Biomedical Sciences, University of Western Australia, Crawley, WA 6009, Australia.; National Centre for Asbestos Related Diseases, Nedlands, WA 6009, Australia., Rinaldi CA; School of Biomedical Sciences, University of Western Australia, Crawley, WA 6009, Australia.; National Centre for Asbestos Related Diseases, Nedlands, WA 6009, Australia.; Centre for Microscopy Characterisation and Analysis, Nedlands, WA 6009, Australia., de Jong E; Telethon Kids Institute, University of Western Australia, West Perth, WA 6872, Australia., Lansley SM; Institute for Respiratory Health, Nedlands, WA 6009, Australia., Gummer JPA; School of Science, Department of Science, Edith Cowan University, Joondalup, WA 6027, Australia.; UWA Medical School, The University of Western Australia, Crawley, WA 6009, Australia., Olasz B; School of Molecular Sciences, University of Western Australia, Crawley, WA 6009, Australia., Nambiar S; School of Veterinary and Life Science, Murdoch University, Murdoch, WA 6150, Australia., Hope DE; School of Biomedical Sciences, University of Western Australia, Crawley, WA 6009, Australia.; National Centre for Asbestos Related Diseases, Nedlands, WA 6009, Australia., Casey TH; School of Biomedical Sciences, University of Western Australia, Crawley, WA 6009, Australia.; National Centre for Asbestos Related Diseases, Nedlands, WA 6009, Australia., Lee YCG; Institute for Respiratory Health, Nedlands, WA 6009, Australia., Leslie C; Department of Anatomical Pathology, PathWest Laboratory Medicine, QEII Medical Centre, Nedlands, WA 6009, Australia., Nealon G; School of Molecular Sciences, University of Western Australia, Crawley, WA 6009, Australia., Shackleford DM; Centre for Drug Candidate Optimisation, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, VIC 3052, Australia., Powell AK; Centre for Drug Candidate Optimisation, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, VIC 3052, Australia., Grimaldi M; IRCM, Institut de Recherche en Cancérologie de Montpellier, Montpellier 34090, France., Balaguer P; IRCM, Institut de Recherche en Cancérologie de Montpellier, Montpellier 34090, France., Zemek RM; Telethon Kids Institute, University of Western Australia, West Perth, WA 6872, Australia., Bosco A; Telethon Kids Institute, University of Western Australia, West Perth, WA 6872, Australia., Piggott MJ; School of Molecular Sciences, University of Western Australia, Crawley, WA 6009, Australia., Vrielink A; School of Molecular Sciences, University of Western Australia, Crawley, WA 6009, Australia., Lake RA; School of Biomedical Sciences, University of Western Australia, Crawley, WA 6009, Australia.; National Centre for Asbestos Related Diseases, Nedlands, WA 6009, Australia., Lesterhuis WJ; School of Biomedical Sciences, University of Western Australia, Crawley, WA 6009, Australia.; National Centre for Asbestos Related Diseases, Nedlands, WA 6009, Australia.; Telethon Kids Institute, University of Western Australia, West Perth, WA 6872, Australia. |
| Source: | IScience [iScience] 2021 Dec 04; Vol. 25 (1), pp. 103571. Date of Electronic Publication: 2021 Dec 04 (Print Publication: 2022). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Cell Press Country of Publication: United States NLM ID: 101724038 Publication Model: eCollection Cited Medium: Internet ISSN: 2589-0042 (Electronic) Linking ISSN: 25890042 NLM ISO Abbreviation: iScience Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
